Local recurrence (n = 45 events) | ||||
---|---|---|---|---|
Variable | Univariable | MVA1 | MVA2 | |
Age | HR | 1.00 | ||
95% CI | 0.96–1.05 | |||
P | 0.84 | |||
ΔMTV | HR | 1.09 | ||
95% CI | 0.96–1.24 | |||
P | 0.19 | |||
Log(MTVpre) | HR | 2.43 | 2.01 | |
95% CI | 1.56–3.78 | 1.25–3.23 | ||
P | 8.4e-5 | 0.004 | ||
Log(MTVmid) | HR | 2.33 | 2.12 | |
95% CI | 1.61–3.37 | 1.47–3.08 | ||
P | 6.8e-5 | 7.1e-5 | ||
Primary Lesion (non-nodal target) | HR | 3.60 | 1.37 | 1.79 |
95% CI | 1.86–6.95 | 0.67–2.79 | 0.86–3.72 | |
P | 0.0001 | 0.38 | 0.12 | |
RT dose | HR | 1.06 | ||
95% CI | 0.97–1.16 | |||
P | 0.17 | |||
Histology | ||||
Adenocarcinoma (ref) | HR | – | ||
95% CI | – | |||
P | – | |||
SCC | HR | 1.89 | ||
95% CI | 0.80–4.46 | |||
P | 0.15 | |||
All others | HR | 1.27 | ||
95% CI | 0.30–5.45 | |||
P | 0.75 |